Sign Up Today and Learn More About Pretzel Therapeutics Stock
Invest in or calculate the value of your shares in Pretzel Therapeutics or other pre-IPO companies through EquityZen's platform.
Pretzel Therapeutics Stock (PRET)
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
About Pretzel Therapeutics Stock
Founded
2019
Headquarters
Waltham, MA, US
Industries
Consumer Goods, Software, Artificial Intelligence
Pretzel Therapeutics Press Mentions
Stay in the know about the latest news on Pretzel Therapeutics
Pretzel Therapeutics presents PX578 data supporting POLG disease treatment
longevity • Mar 14, 2026
First-in-class POLG activator restores mtDNA across mutations
bioworld • Mar 13, 2026
Pretzel Therapeutics Presents Preclinical Data on PX578 at MDA 2026, Further Supporting Clinical Advancement in Individuals Living with POLG Disease
biospace • Mar 12, 2026
Pretzel Therapeutics Advances Mitochondrial Medicine with Strategic Growth
pharmiweb • Jan 16, 2026
Pretzel emerges as winner from rise and fall of Rome Therapeutics
fiercebiotech • Jan 16, 2026
Pretzel Therapeutics Management
Leadership team at Pretzel Therapeutics
Board of Directors
Robert Tansley
Board of Directors
Jay Parrish
Join now and verify your accreditation status to gain access to:
- Pretzel Therapeutics Current Valuation
- Pretzel Therapeutics Stock Price
- Pretzel Therapeutics Management
- Available deals in Pretzel Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Pretzel Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Pretzel Therapeutics Revenue and Financials
- Pretzel Therapeutics Highlights
- Pretzel Therapeutics Business Model
- Pretzel Therapeutics Risk Factors
- Pretzel Therapeutics Research Report from SACRA Research
Trading Pretzel Therapeutics Stock
How to invest in Pretzel Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Pretzel Therapeutics through EquityZen funds. These investments are made available by existing Pretzel Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Pretzel Therapeutics stock?
Shareholders can sell their Pretzel Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
